Hania Sholkamy’s biography, fact, career, awards, net worth and life story

Intro Egyptian anthropologist
A.K.A. Hania Mohamed Sholkamy
Is Anthropologist
From Egypt
Type Social science
Gender female
Birth

27 February 1964

Age 56 years
Star sign Pisces

Professor Hania Mohamed Sholkamy (born 27 February 1964) is a lead researcher of the Egyptian Conditional Cash Transfer (CCT) programme and an anthropologist based at the American University in Cairo.

Sholkamy is a feminist researcher from the Social Research Centre at the American University in Cairo whose research explores issues of reproductive health. She has published various articles on political and social topics particularly in Egypt and the middle Eastern Region, and has spoken and written on topics including rituals around marriage and infants. Sholkamy was a Centennial Carnegie Visiting Scholar at Yale University and before this was a Junior Research Fellow at St. Anne’s College, Oxford University.

In addition to her research at the university, Sholkamy leads the Egyptian Conditional Cash Transfer (CCT) programme, which aims at transforming social protection to women in Egypt.

Sholkamy is one of the advisors to the United Nations Research Institute For Social Development project on human rights and social protection and has previously worked on other United Nations projects.

Education

Sholkamy received her Ph.D. in Social Anthropology from The London School of Economics and Political Science in 1997. She was a Chevening Scholar. Prior to this, she got her M.A in 1988 in Social Anthropology from American University in Cairo. Her B.A was in Middle Eastern Studies in 1985 from American University in Cairo.

You May Also Like

Randal Kirk’s net worth, biography, fact, career, awards and life story

Randal Kirk net worth: Randal Kirk is an American businessman who has an estimated net worth of $3.6 billion dollars. Born in Pleasonton, California, Randal Kirk moved around a great deal as a child, since his father was in the military. He earned his undergraduate degree from Radford University in Economics, and then went on to earn a law degree from the University of Virginia. In the mid-80s, he co-founded General Injectables and Vaccines, a Virginia-based pharmaceuticals company. The company spun off another pharmaceuticals company, based in Tennessee, called King Pharmaceuticals. The co-founders subsequently split, with each one taking a company. Mr. Kirk sold his portion for $65 million in cash. He then founded New River Pharmaceuticals in the mid-90s, and became CEO in 2001. He sold the company for $2.6 billion in 2007. He then launched a management investment firm, and another pharmaceutical company, called Clinical Data. He sold Clinical Data for $2.1 billion in 2011. He is currently focused on his new company, Intrexon.
Read More